Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide Dose Reduction in Compensated CHF
NCT00982423Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2009
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of furosemide in heart failure (HF), sponsored by Mayo Clinic. Primary endpoint: Glomerular Filtration Rate at 6 weeks. Started Jul 2009; status: completed.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00982423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00982423.